CM
ARCT icon

Caption Management’s Arcturus Therapeutics ARCT Stock Holding History

Caption Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,464
Closed -$1.08M – 1557
2025
Q3 		$1.08M Buy
+58,464
New +$939K 0.01% 1074
2025
Q1 		– Sell
-9,800
Closed -$166K – 1498
2024
Q4 		$166K Buy
+9,800
New +$184K ﹤0.01% 1304
2022
Q4 		– Sell
-15,000
Closed -$222K – 1262
2022
Q3 		$222K Hold
15,000
– – ﹤0.01% 1230
2022
Q2 		$236K Buy
+15,000
New +$294K ﹤0.01% 1209

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Caption Management's ARCT Position: Q4 2025 in Review

Caption Management sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 58,464 shares — an estimated $1.08M sold.

Caption Management first reported a position in ARCT in Q2 2022 and held it in 4 quarters. The position peaked at $1.08M in Q3 2025. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Caption Management reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 58,464 Arcturus Therapeutics shares in Q4 2025, an estimated $1.08M.
  • Caption Management first reported a position in Arcturus Therapeutics in Q2 2022 and held it in 4 quarters.
  • Caption Management's Arcturus Therapeutics position peaked at $1.08M in Q3 2025.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.